Tilray Brands Announces Next Phase of Beverage Transformation

Successfully Completed Consolidation of U.S. Brewing Footprint from 10 Facilities to Six Identifying Further Opportunities to Reduce Complexity, Improve Brewery Utilization and Strengthen Margins Transformation Initiatives Strengthen Operational Footprint Ahead of the Carlsberg U.S. Partnership Launching January 1, 2027; Targeting One Million Cases in First-Year Sales Through Tilray's Existing Production and Distribution Infrastructure Reaffirms Fiscal 2027 Adjusted EBITDA Guidance of $68 million to $75 million NEW YORK and LONDON and LEAMINGTON, Ontario, Oct. 29, 2026 (GLOBE NEWSWIRE) -- Tilray Brands, Inc. (“Tilray” or the “Company”) (Nasdaq: TLRY; TSX: TLRY), a global lifestyle and consumer packaged goods company with leading positions across cannabis, beverage, hospitality and wellness, today announced additional initiatives across its U.S. beverage business, designed to reduce complexity and increase operational efficiency, targeting approximately $20 million in annualized cost savings by the end of fiscal 2028. Having now consolidated its U.S. brewing footprint from 10 facilities to six, Tilray is well-positioned to enter the next phase of transformation of its U.S. beverage business, pursuing additional opportunities across manufacturing, warehousing, procurement and logistics to lower production costs and increase utilization at its remaining breweries.

GlobeNewsWire • 14 hours ago

Down 70% in 2026, Has Tilray's Stock Finally Bottomed Out?

Tilray's low valuation may be enticing to investors as its market cap is just $400 million. The business, however, struggles to grow organically on a consistent basis.

The Motley Fool • Oct 27, 2026

Tilray Now Sells More Beer Than Cannabis. Here's Why That Might Be Good News for Investors.

Tilray started out as a pure-play marijuana company. The company has since decided to shift toward a consumer staples approach, selling branded products beyond pot.

The Motley Fool • Oct 25, 2026

Blue Point Brewing Co.'s Legendary Cask Ales Festival Returns to Patchogue with 100+ Limited-Release Brews

PATCHOGUE, N.Y., Oct. 22, 2026 (GLOBE NEWSWIRE) -- One of Long Island's longest-running craft beer celebrations is returning to Main Street.

GlobeNewsWire • Oct 22, 2026

West Ham United F.C. and BrewDog Unveil Boleyn Brew: A Fan-Created Matchday Beer Made by Hammers, for Hammers

ELLON, Scotland and LONDON, Oct. 21, 2026 (GLOBE NEWSWIRE) -- BrewDog , a leader in U.K. craft beer and one of the world's most recognised beer brands, owned by Tilray Brands, Inc. (NASDAQ: TLRY; TSX: TLRY), and West Ham United Football Club today unveiled Boleyn Brew, a first-of-its-kind fan-created beer built with West Ham supporters and brewed for matchday. From flavour and style to storytelling, branding and name, Hammers helped shape every part of the beer.

GlobeNewsWire • Oct 21, 2026

SweetWater Brewing Gives Fans the Chance to Win Tickets to Their Dream Show at AEG Venues Across Georgia

Crack Open the Good Times: Fans 21+ Can Scan the SweetWater QR Code in or Enter Online for a Shot at a Night Out at Georgia Theatre, The Eastern, Variety Playhouse, or Terminal West Crack Open the Good Times: Fans 21+ Can Scan the SweetWater QR Code in or Enter Online for a Shot at a Night Out at Georgia Theatre, The Eastern, Variety Playhouse, or Terminal West

GlobeNewsWire • Oct 15, 2026

Canopy Growth vs. Tilray Brands: Which Cannabis Stock Is a Better Buy in 2026?

Canopy Growth maintains a strategic focus on premium cannabis products and European medical distribution. Tilray Brands has expanded into the craft beverage and wellness markets to diversify its revenue streams.

The Motley Fool • Oct 15, 2026

BrewDog Acquisition Boosts Tilray's Q1 Performance

Tilray reported Q1-2027 financial results last week with increasing revenue from its BrewDog operations; Cannabis revenue decreased. The company expects its new beer assets along with its international cannabis operations to continue to drive growth. The company reported a net loss and negative free cash flow.

Seeking Alpha • Oct 13, 2026

Tilray Medical Strengthens Global Medical Cannabis Supply Chain with Approval to Bring Critical EU-GMP Quality Testing In-House, Accelerating Product Release Across Regulated Global Markets

CANTANHEDE, Portugal, Oct. 13, 2026 (GLOBE NEWSWIRE) -- Tilray Medical, a global leader in medical cannabis research, cultivation, production, products and distribution and a division of Tilray Brands, Inc. (“Tilray”) (Nasdaq: TLRY; TSX: TLRY), today announced a key regulatory milestone in Europe: INFARMED, Portugal's National Authority of Medicines and Health Products, has approved the quality control laboratory at Tilray Medical's EU-GMP-certified facility in Cantanhede, Portugal, to conduct microbiological and chemical/physical testing in-house. The approval gives Tilray Medical greater command over critical quality testing, accelerates product release capabilities, and strengthens its Portugal facility as a strategic launchpad for pharmaceutical-grade medical cannabis supply across regulated international markets.

GlobeNewsWire • Oct 13, 2026

3 Huge Red Flags From Tilray's Q1 Earnings Report

Tilray's cash burn continues to be a big problem for investors. The business has been growing through acquisitions, and while that can boost the top line, it can also lead to significantly higher expenses.

The Motley Fool • Oct 12, 2026